Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

OBJECTIVES: To evaluate the relationship between bone mineral density (BMD) and biomarkers of bone turnover and inflammation in patients with ankylosing spondylitis (AS) treated with infliximab. METHODS: Patients (n = 279) were randomly assigned (3:8) to receive placebo or 5 mg/kg infliximab every 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Visvanathan, S, van der Heijde, D, Deodhar, A, Wagner, C, Baker, D G, Han, J, Braun, J
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605572/
https://www.ncbi.nlm.nih.gov/pubmed/18495735
http://dx.doi.org/10.1136/ard.2007.084426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605572/
https://www.ncbi.nlm.nih.gov/pubmed/18495735
http://dx.doi.org/10.1136/ard.2007.084426

Ejemplares similares